Cost benefit analysis of the use of tranexamic acid in primary lower limb arthroplasty: A retrospective cohort study

Table 1 Patient demographics

	Control group(n = 100)	TXA group(n = 100)	P value
Male/female	49/51	44/56	0.47
Age in years	62.57 ± 12.14	62.9 ± 12.6	0.86
THR/TKR	60/40	52/48	0.25
Pre-operative Hgb	13.61 ± 1.42	13.77 ± 1.41	0.43
Pre-operative Hct	0.41 ± 0.04	0.41 ± 0.04	0.32
Pre-operative platelets	253.01 ± 55.87	256.85 ± 69.75	0.67

THR: Total hip replacement; TKR: Total knee replacement; Hgb: Haemoglobin; Hct: Haematocrit; TXA: Tranexamic acid.